Concert Pharmaceuticals makes appointments
This article was originally published in Scrip
Concert Pharmaceuticals, a US clinical-stage biotechnology company focused on the application of deuterium chemistry to create small-molecule drugs, has appointed Dr Lijun Wu vice-president of biology. She was previously vice-president of discovery research at Resolvyx Pharmaceuticals. Concert has also elected Dr Lee Brettman, chief medical officer of Alnara Pharmaceuticals, and Dr Dennis Giesing, head of research at Cortria, to its product advisory board.